Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Euclidean Capital LLC 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Euclidean Capital LLC (CIK 1825034) reported $439.8M across 11 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: VEU ($271.6M, 61.76%), VTV ($113.3M, 25.76%), INDA ($18.3M, 4.15%), ORIC ($10.7M, 2.44%), TMS ($9.0M, 2.06%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1VEUVANGUARD INTL EQUITY INDEX F$271.6M61.76%3.2MHold
2VTVVANGUARD INDEX FDS$113.3M25.76%520,000Hold
3INDAISHARES TR$18.3M4.15%369,600Hold
4ORICORIC PHARMACEUTICALS INC$10.7M2.44%989,410Hold
5TMSTEAMSHARES INC$9.0M2.06%1.1MNew
6FHTXFOGHORN THERAPEUTICS INC$7.7M1.75%1.6MHold
7PMVPPMV PHARMACEUTICALS INC$3.5M0.80%2.6MHold
8ALECALECTOR INC$2.6M0.60%1.3MHold
9SRZNSURROZEN INC$2.3M0.52%87,696Hold
10TNYATENAYA THERAPEUTICS INC$750,7080.17%1.0MHold
11SRZNWSURROZEN INC$2,8190.00%170,833Hold

Source: SEC Form 13F filings · as of 2026-06-30